AKTX

Akari Therapeutics PLC

Price

$7.87

return (12m)

-77.77%

p/e

p/bv

DIVIDEND YIELD

0.00%

AKTX price

Akari Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment AKTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-7.41%

3 months

-50.58%

1 year

-77.77%

2 years

-94.88%

5 years

-99.47%

10 years

-99.90%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals AKTX

Valuation

P/E

Sector -0.74

Industry 10.34

P/BV

Sector 1.96

Industry 2.60

P/Revenue (PSR)

Sector 1.73

Industry 1.16

EV/EBITDA

Sector -18.94

Industry 27.24

EV/EBIT

Sector -26.38

Industry -33.91

P/EBITDA

Sector -44.48

Industry -84.29

P/EBIT

Sector -45.47

Industry 2.31

P/Total Assets

Sector 0.91

Industry 1.17

P/Net Current Assets

-91,424.25

Sector -25.25

Industry -3.78

P/Working Capital

-190,494.30

Sector -5.75

Industry 6.90

EPS

0.00

Sector -0.83

Industry 1.21

BVPS

0.00

Sector 3.90

Industry 15.16

Efficiency

Gross Margin

0.00%

Sector 45.46%

Industry 29.23%

EBITDA Margin

Sector -311.16%

Industry 4.54%

EBIT Margin

Sector -197.35%

Industry 3.11%

Operating Margin

0.00%

Sector -22.95%

Industry 2.73%

Net Profit Margins

0.00%

Sector -28.26%

Industry 3.05%

Asset Turnover

0.00

Sector 0.13

Industry 0.28

Profitability

ROE

-166.59%

Sector -30.03%

Industry 8.27%

ROA

-80.19%

Sector -28.65%

Industry 3.60%

ROIC

0.00%

Sector -521.05%

Industry -2.36%

Dividends

Dividend yield

0.00%

Sector -

Industry 0.01%

Payout

Sector -

Industry 0.78%

Debt

Current Ratio

0.60

Sector 1.85

Industry 1.48

Net Debt / EBITDA

Sector -4.36

Industry -4.26

Net Debt / EBIT

Sector -2.89

Industry -0.72

Net Debt / Equity

0.00

Sector -0.42

Industry 0.04

Gross Debt / Equity

0.00

Sector -0.57

Industry 0.37

Equity/Assets

0.48

Sector 0.43

Industry 0.46

Liabilities/Assets

0.52

Sector 0.48

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals AKTX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
AKTX Akari Therapeutics PLC	$7.87	-78.65%	0.00%	0.00	0.00	-166.59%	0.00%
LLY Eli Lilly and Compay	$1,246.93	80.86%	0.52%	41.58	-	-%	33.53%
SNY Sanofi	$46.02	-6.85%	3.87%	7.43	1.37	18.43%	13.81%
GSK GlaxoSmithKline PLC	$51.78	34.76%	3.42%	15.92	4.50	28.24%	14.54%
CRMD CorMedix Inc.	$8.56	-37.47%	0.00%	3.45	1.40	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$21.98	-27.93%	0.00%	12.05	1.23	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.21	-15.28%	0.68%	27.69	2.50	9.03%	10.14%
ISRG Intuitive Surgical Inc.	$371.84	-21.91%	0.00%	41.88	7.23	17.26%	28.62%
NVS Novartis AG	$158.02	26.86%	1.96%	28.21	7.75	27.47%	26.57%
TMO Thermo Fisher Scientific Inc.	$628.74	26.29%	0.29%	33.36	4.42	13.26%	15.08%
ABT Abbott Laboratories	$116.13	-9.92%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$92.90	4.26%	3.09%	24.60	2.36	9.59%	13.20%
BSX Boston Scientific Corp.	$49.86	-53.04%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.60	-21.90%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$559.51	-13.33%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$232.45	-19.86%	1.04%	22.12	5.18	23.41%	27.44%
DHR Danaher Corporation	$215.11	4.32%	0.67%	37.88	2.88	7.61%	15.95%
HCA HCA Healthcare Inc.	$429.24	6.69%	0.70%	12.08	-29.56	-244.72%	10.07%
COHR Coherent Inc.	$288.14	220.51%	0.00%	115.66	4.75	4.11%	6.85%
PHG Koninklijke Philips NV	$27.43	0.60%	3.68%	20.31	1.99	9.80%	6.30%
SYK Stryker Corp.	$327.81	-15.78%	1.06%	33.67	5.23	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

AKTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Akari Therapeutics

Akari Therapeutics PLC

Average Investor10 user rating

4.0 (2 people)

United States

22 years

Founded: 2004

2012

Time since IPO - 14 years

10

Employees

Akari Therapeutics PLC (United States) is listed on the Nasdaq and has a market capitalization of $1.07 trillion, with shareholders equity totaling $18.59 million.

The company employs approximately 10 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Akari Therapeutics PLC reported $- in revenue, generating net income of $-30.97 million.

Key financial metrics include a P/E ratio of -, a price-to-book (P/B) ratio of -, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker AKTX.

Market cap

$1.07 trillion

Net worth

$18.59 million

$18,590,000.00

Assets

$38.62 million

$38,620,000.00

Total Shares Outstanding

143.32 billion

143,317,000,000

Average Daily Trading Volume

$65.27 Thousand

$65,266.12

Sector

Health

Industry

Pharmaceutical Products

AKTX

AKTX revenue and profits

Financial Results AKTX

DRAG THE FRAME TO SEE MORE DATA

AKTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$92.90 34,58% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$280.45 --4,70% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$65.63 125,69% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$386.61 31,97% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$46.02 --4,58% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,246.93 71,05% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$429.24 7,27% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$158.02 28,83% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75